TrivarX Limited (ASX:TRI)
Australia
· Delayed Price · Currency is AUD 0.0220
-0.0010 (-4.35%)
At close: Mar 9, 2026
TrivarX Revenue
TrivarX had revenue of 2.27K AUD in the half year ending December 31, 2025, a decrease of -89.39%. This brings the company's revenue in the last twelve months to -95.36K, down -104.78% year-over-year. In the fiscal year ending June 30, 2025, TrivarX had annual revenue of 1.03M with 16.00% growth.
Revenue (ttm)
-95.36K
Revenue Growth
-104.78%
P/S Ratio
-266.17
Revenue / Employee
-15.89K
Employees
6
Market Cap
25.38M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.03M | 142.24K | 16.00% |
| Jun 30, 2024 | 888.83K | -71.62K | -7.46% |
| Jun 30, 2023 | 960.45K | -45.00K | -4.48% |
| Jun 30, 2022 | 1.01M | -258.10K | -20.43% |
| Jun 30, 2021 | 1.26M | 338.28K | 36.56% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ImExHS | 28.97M |
| PainChek | 3.44M |
| Resonance Health | 13.84M |
| Emyria | 2.29M |
| Vitasora Health | 5.01M |
| Beamtree Holdings | 28.90M |
| Pathkey.AI | 290.26K |
| Adheris Health | 40.60M |